Patient Mortality Up With End-of-Rotation Team Transition

Share this content:
Patient Mortality Up With End-of-Rotation Team Transition
Patient Mortality Up With End-of-Rotation Team Transition

TUESDAY, Dec. 6, 2016 (HealthDay News) -- Hospitalized patients who are handed off by their original medical team to a new set of caregivers may ultimately face a higher risk of early mortality, according to research published in the Dec. 6 issue of the Journal of the American Medical Association, a theme issue on medical education.

Researchers looked at the experiences of 230,701 patients being cared for at one of 10 U.S. Veterans Health Administration hospitals between 2008 and 2014. Most (95.8 percent) were men, average age 65.6, and the median hospital stay was just three days. Just over 2 percent of the patients died in hospital (2.18 percent), while 9.45 and 14.43 percent died within a month or three months after discharge, respectively.

Overall, the risk of dying both while in hospital or soon after discharge (at 30 and 90 days out) was significantly greater among those patients who underwent an end-of-rotation transfer while hospitalized, compared with those who didn't. Elevated risk only went up significantly among transfers handled either by interns alone, or by an intern/resident team. Apart from training status, the apparent rise in mortality risk held up across age, gender, race, ethnicity, or length of hospital stay.

In a second study in the same journal, Charlie Wray, D.O., from the San Francisco Veterans Affairs Medical Center, and colleagues examined routine adherence to national recommendations regarding ideal rotation policies, such as providing a dedicated time and place for patient hand-offs and/or ensuring hand-off supervision by senior physicians. The responses varied widely, with adherence ranging from just 6 percent in some cases to 67 percent in others, depending on the particular recommendation in question.

Full Text 1 (subscription or payment may be required)
Full Text 2 (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »